Topic
Semiconductor Research
Research across global markets indicates a robust environment for technology-related sectors, driven largely by Nasdaq outperformance and the ongoing integration of AI. The transition of biotechnology toward a scalable industry relies heavily on AI-driven drug discovery, a trend that underscores the increasing importance of high-performance computing infrastructure. Tactical regional themes, particularly in Asian technology, are highlighted as key opportunities for satellite portfolios seeking growth. Furthermore, the global tech economy’s strength is reflected in institutional hedging shifts and record equity highs, despite market caution regarding the exact pace of AI monetization. Recent technical moves, including a 25-year record outperformance in software relative to the S&P 500, suggest a period of high factor volatility and concentrated demand in tech-adjacent growth sectors. As markets navigate these geopolitical and technical shifts, analysts recommend enhancing portfolio resilience through exposure to resilient global markets like Japan and diversifying into alternative assets.
4293 reports available
All reports
Page 72 of 179
DBDaily
Deutsche Bank · Jun 9, 2026
Daily Points
Scotiabank · Jun 9, 2026
Looking Under the ETF Hood
Convexity Maven · Jun 9, 2026
Fixed Income Weekly Update
Piper Sandler · Jun 9, 2026
Daily Europe
UBS · Jun 9, 2026
Lyell Immunopharma Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
GS Morning Market Update
Goldman Sachs · Jun 9, 2026
AI Volatility Is Back But The Capex Story Still Looks Firm
UBS · Jun 9, 2026
The 720 Japan Tech China Internet And Corporate Strategy Updates
Goldman Sachs · Jun 9, 2026
GS Sustain: The Reliability Imperative
Goldman Sachs · Jun 9, 2026
The Day Ahead North America
London Stock Exchange Group · Jun 9, 2026
BoJ Monetary Policy Meeting Preview
Citi · Jun 9, 2026
Weekly Interest Rate Monitor
Raymond James · Jun 9, 2026
Italian Banks First Thoughts On M&A Scenarios
Barclays · Jun 9, 2026
Global Macro Monthly
TS Lombard · Jun 9, 2026
Oric Pharmaceuticals Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
Sino Biopharmaceutical Key Takeaways
Goldman Sachs · Jun 9, 2026
Teva Pharmaceuticals Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
Turkiye Banks Sector Trends
Goldman Sachs · Jun 9, 2026
GS Basics - Token Expenditure Apple Monetization Debate
Goldman Sachs · Jun 9, 2026
Tandem Diabetes Care Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
Seaport Therapeutics Additional Phase 1 Data Validates the Glyph Platform
Goldman Sachs · Jun 9, 2026
Barclays Equity Factor Insights
Barclays · Jun 9, 2026
GS European Express
Goldman Sachs · Jun 9, 2026